Back

Association of renin-angiotensin system inhibition with clinical outcomes in patients undergoing transcatheter aortic valve replacement: analysis from the STS/ACC TVT Registry

28 August 2018 (15:50 - 16:40)
Organised by:
Congress Presentation Part of: Outcome prediction tools after valve intervention Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Taku Inohara

Keio University School of Medicine, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
Impact of elixhauser comorbidity score on the outcomes of transcatheter aortic valve replacement
Doctor V. Nagaraja (Rochester, US)
Abstract Slides
Presentation thumbnail
Prevalence and prognostic impact of prosthesis-patient mismatch after transcatheter aortic valve implantation
Doctor N. Schofer (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Temporal trends on percutaneous mitral commissurotomy: 30 years of experience
Doctor C. Desnos (Paris, FR)
Abstract Slides
Presentation thumbnail
Development of immediate and late predictor score of success after percutaneous mitral valvoplasty in patients with mitral stenosis
Doctor J. Costa Jr (Sao Paulo, BR)
Presentation thumbnail
Prognostic value of logistic EuroSCORE and STS-PROM in a recent patient cohort undergoing TAVI with next generation transcatheter heart valves
Mr B. Al-Kassou (Bonn, DE)
Abstract Slides

Access the full session

Session thumbnail
Outcome prediction tools after valve intervention

The Event

Event poster

ESC Congress 2018

28 August 2018 15:50 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources